Clinical trial Recruiting at 1 site Interventional Ages 40 and up

Program of care for patients with COPD after hospital discharge

Official title: A Program of Care in Chronic Obstructive Pulmonary Disease Involving Virtual Pulmonary Rehabilitation, Integrated Care and Remote Clinical Monitoring After Discharge From a Recent Exacerbation: Mixed-Methods Study on Feasibility

Run by University Health Network, Toronto · NCT06253013 · Data updated 2026-11-12

This study is testing a new care program that uses technology to help patients with COPD after they leave the hospital to see if it can keep them healthier and reduce the chances of going back to the hospital.

More Chronic Obstructive Pulmonary Disease trials

Quick facts

Study typeInterventional
Ages40 Years and up
SexAll
Enrollment100 (estimated)
SponsorUniversity Health Network, Toronto
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedSeptember 15, 2023
Main results expectedJune 2027
Study endsJune 2027
Registry record updatedJune 22, 2026
Trial IDNCT06253013 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with COPD who have been recently discharged from the hospital after an acute exacerbation.

Probably not a fit

Patients with pulmonary conditions other than COPD or those with significant cognitive impairments may not benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to evaluate the feasibility, acceptability, and usage of a comprehensive care program for patients with Chronic Obstructive Pulmonary Disease (COPD) who have recently been discharged following an acute exacerbation. The program integrates virtual pulmonary rehabilitation, remote clinical monitoring, and personalized care strategies, utilizing technologies such as smartwatches and home spirometers. The study will assess whether this multimodal approach is beneficial for patients and healthcare providers, and whether it can effectively reduce hospital readmissions. Additionally, the feasibility of conducting a larger randomized control trial will be explored.

Why it matters

Potential benefit: If successful, this program could significantly improve the management of COPD and reduce hospital readmissions for patients.

How similar studies have gone: Other studies have shown promise in using remote monitoring and digital health technologies for managing chronic diseases, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Referred to either Virtual Pulmonary Rehabilitation or Remote Clinical Monitoring at Toronto Grace Health Centre after discharge from UHN hospital with an AECOPD as defined by the clinical team

Exclusion Criteria:

* Pulmonary condition other than COPD as the main respiratory disease such as bronchiectasis or asthma
* Projected life expectancy ≤ 2 months , as determined by the clinical team
* Significant cognitive impairment and absence/inability of a family caregiver to consent and to follow study processes

Where it's running

  • University Health Network
    Toronto, Ontario, Canada
    Recruiting

Study contacts

  • Principal investigator: Robert Wu, MD — University Health Network, Toronto
  • Study coordinator: Alice Tu, MA
  • Email: alice.tu2@uhn.ca
  • Phone: 647-381-7024

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.